- Home
- AIMD vs INBS Comparison
AIMD vs INBS Comparison
Compare AIMD & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- INBS
- Stock Information
- Founded
- AIMD 1984
- INBS 2016
- Country
- AIMD United States
- INBS United States
- Employees
- AIMD N/A
- INBS N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- AIMD Health Care
- INBS Health Care
- Exchange
- AIMD Nasdaq
- INBS Nasdaq
- Market Cap
- AIMD 11.9M
- INBS 11.7M
- IPO Year
- AIMD N/A
- INBS N/A
- Fundamental
- Price
- AIMD $3.63
- INBS $1.52
- Analyst Decision
- AIMD
- INBS
- Analyst Count
- AIMD 0
- INBS 0
- Target Price
- AIMD N/A
- INBS N/A
- AVG Volume (30 Days)
- AIMD 235.1K
- INBS 114.9K
- Earning Date
- AIMD 08-13-2025
- INBS 08-15-2025
- Dividend Yield
- AIMD N/A
- INBS N/A
- EPS Growth
- AIMD N/A
- INBS N/A
- EPS
- AIMD N/A
- INBS N/A
- Revenue
- AIMD $110,870.00
- INBS $3,052,532.00
- Revenue This Year
- AIMD N/A
- INBS $778.48
- Revenue Next Year
- AIMD N/A
- INBS N/A
- P/E Ratio
- AIMD N/A
- INBS N/A
- Revenue Growth
- AIMD 70.25
- INBS N/A
- 52 Week Low
- AIMD $2.00
- INBS $1.10
- 52 Week High
- AIMD $5.00
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- AIMD 54.86
- INBS 46.08
- Support Level
- AIMD $3.56
- INBS $1.40
- Resistance Level
- AIMD $4.19
- INBS $1.70
- Average True Range (ATR)
- AIMD 0.27
- INBS 0.10
- MACD
- AIMD -0.01
- INBS 0.02
- Stochastic Oscillator
- AIMD 38.46
- INBS 44.62
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).